10-Q 1 well-20240630.htm 10-Q well-20240630
0000766704false2024Q2December 31P1Yhttp://www.welltower.com/20240630#LeaseRightOfUseAssethttp://www.welltower.com/20240630#LeaseRightOfUseAssethttp://www.welltower.com/20240630#LeaseRightOfUseAssethttp://www.welltower.com/20240630#LeaseRightOfUseAssethttp://www.welltower.com/20240630#ReceivablesAndOtherAssetshttp://www.welltower.com/20240630#ReceivablesAndOtherAssetshttp://www.welltower.com/20240630#LeaseLiabilityhttp://www.welltower.com/20240630#LeaseLiabilityhttp://www.welltower.com/20240630#LeaseLiabilityhttp://www.welltower.com/20240630#LeaseLiabilityP3Yxbrli:sharesiso4217:USDiso4217:USDxbrli:sharesxbrli:purewell:propertywell:joint_venturewell:projectwell:loanwell:propertieswell:partnerwell:bankiso4217:CADwell:Termwell:termiso4217:GBPwell:obligationwell:segment00007667042024-01-012024-06-300000766704us-gaap:CommonStockMember2024-01-012024-06-300000766704well:GuaranteeNotesDue20284800Member2024-01-012024-06-300000766704well:GuaranteeNotesDue20344500Member2024-01-012024-06-3000007667042024-07-2600007667042024-06-3000007667042023-12-3100007667042024-04-012024-06-3000007667042023-04-012023-06-3000007667042023-01-012023-06-300000766704us-gaap:CommonStockMember2023-12-310000766704us-gaap:AdditionalPaidInCapitalMember2023-12-310000766704us-gaap:TreasuryStockCommonMember2023-12-310000766704us-gaap:RetainedEarningsUnappropriatedMember2023-12-310000766704well:AccumulatedDistributionsMember2023-12-310000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310000766704us-gaap:NoncontrollingInterestMember2023-12-310000766704us-gaap:RetainedEarningsUnappropriatedMember2024-01-012024-03-310000766704us-gaap:NoncontrollingInterestMember2024-01-012024-03-3100007667042024-01-012024-03-310000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310000766704us-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-310000766704us-gaap:CommonStockMember2024-01-012024-03-310000766704us-gaap:TreasuryStockCommonMember2024-01-012024-03-310000766704well:AccumulatedDistributionsMember2024-01-012024-03-310000766704us-gaap:CommonStockMember2024-03-310000766704us-gaap:AdditionalPaidInCapitalMember2024-03-310000766704us-gaap:TreasuryStockCommonMember2024-03-310000766704us-gaap:RetainedEarningsUnappropriatedMember2024-03-310000766704well:AccumulatedDistributionsMember2024-03-310000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-310000766704us-gaap:NoncontrollingInterestMember2024-03-3100007667042024-03-310000766704us-gaap:RetainedEarningsUnappropriatedMember2024-04-012024-06-300000766704us-gaap:NoncontrollingInterestMember2024-04-012024-06-300000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-04-012024-06-300000766704us-gaap:AdditionalPaidInCapitalMember2024-04-012024-06-300000766704us-gaap:CommonStockMember2024-04-012024-06-300000766704us-gaap:TreasuryStockCommonMember2024-04-012024-06-300000766704well:AccumulatedDistributionsMember2024-04-012024-06-300000766704us-gaap:CommonStockMember2024-06-300000766704us-gaap:AdditionalPaidInCapitalMember2024-06-300000766704us-gaap:TreasuryStockCommonMember2024-06-300000766704us-gaap:RetainedEarningsUnappropriatedMember2024-06-300000766704well:AccumulatedDistributionsMember2024-06-300000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-300000766704us-gaap:NoncontrollingInterestMember2024-06-300000766704us-gaap:CommonStockMember2022-12-310000766704us-gaap:AdditionalPaidInCapitalMember2022-12-310000766704us-gaap:TreasuryStockCommonMember2022-12-310000766704us-gaap:RetainedEarningsUnappropriatedMember2022-12-310000766704well:AccumulatedDistributionsMember2022-12-310000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310000766704us-gaap:NoncontrollingInterestMember2022-12-3100007667042022-12-310000766704us-gaap:RetainedEarningsUnappropriatedMember2023-01-012023-03-310000766704us-gaap:NoncontrollingInterestMember2023-01-012023-03-3100007667042023-01-012023-03-310000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310000766704us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310000766704us-gaap:CommonStockMember2023-01-012023-03-310000766704us-gaap:TreasuryStockCommonMember2023-01-012023-03-310000766704well:AccumulatedDistributionsMember2023-01-012023-03-310000766704us-gaap:CommonStockMember2023-03-310000766704us-gaap:AdditionalPaidInCapitalMember2023-03-310000766704us-gaap:TreasuryStockCommonMember2023-03-310000766704us-gaap:RetainedEarningsUnappropriatedMember2023-03-310000766704well:AccumulatedDistributionsMember2023-03-310000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310000766704us-gaap:NoncontrollingInterestMember2023-03-3100007667042023-03-310000766704us-gaap:RetainedEarningsUnappropriatedMember2023-04-012023-06-300000766704us-gaap:NoncontrollingInterestMember2023-04-012023-06-300000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-012023-06-300000766704us-gaap:AdditionalPaidInCapitalMember2023-04-012023-06-300000766704us-gaap:CommonStockMember2023-04-012023-06-300000766704us-gaap:TreasuryStockCommonMember2023-04-012023-06-300000766704well:AccumulatedDistributionsMember2023-04-012023-06-300000766704us-gaap:CommonStockMember2023-06-300000766704us-gaap:AdditionalPaidInCapitalMember2023-06-300000766704us-gaap:TreasuryStockCommonMember2023-06-300000766704us-gaap:RetainedEarningsUnappropriatedMember2023-06-300000766704well:AccumulatedDistributionsMember2023-06-300000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-300000766704us-gaap:NoncontrollingInterestMember2023-06-3000007667042023-06-300000766704well:WelltowerOPIncMember2024-01-012024-06-300000766704well:WelltowerOPIncMember2024-06-300000766704well:OtherInvestorsMemberwell:WelltowerOPIncMember2024-06-300000766704well:SeniorHousingOperatingMember2024-06-300000766704well:TripleNetMember2024-06-300000766704well:OutpatientMedicalMember2024-06-300000766704well:SeniorHousingOperatingMember2023-06-300000766704well:TripleNetMember2023-06-300000766704well:OutpatientMedicalMember2023-06-300000766704well:SeniorHousingOperatingMember2024-01-012024-06-300000766704well:TripleNetMember2024-01-012024-06-300000766704well:OutpatientMedicalMember2024-01-012024-06-300000766704well:SeniorHousingOperatingMember2023-01-012023-06-300000766704well:TripleNetMember2023-01-012023-06-300000766704well:OutpatientMedicalMember2023-01-012023-06-300000766704well:SeniorsHousingOperatingPropertiesAffinityBrandMember2024-02-290000766704well:SeniorsHousingOperatingPropertiesAffinityBrandMember2024-02-012024-02-290000766704well:SeniorsHousingRealEstatePortfolioMemberus-gaap:SubsequentEventMember2024-07-012024-07-300000766704us-gaap:LeasesAcquiredInPlaceMember2024-06-300000766704us-gaap:LeasesAcquiredInPlaceMember2023-12-310000766704us-gaap:AboveMarketLeasesMember2024-06-300000766704us-gaap:AboveMarketLeasesMember2023-12-310000766704well:LeaseCommissionsMember2024-06-300000766704well:LeaseCommissionsMember2023-12-310000766704us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember2024-04-012024-06-300000766704us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember2023-04-012023-06-300000766704well:ReveraJointVentureAcquisitionTransactionMember2023-04-012023-06-300000766704well:ReveraJointVentureDisposalTransactionMember2023-04-012023-06-300000766704well:ReveraJointVentureAcquisitionTransactionMember2023-06-012023-06-300000766704well:UKPortfolioReveraJointVentureMember2023-06-300000766704well:UKPortfolioReveraJointVenture1Member2023-06-300000766704well:UKPortfolioReveraJointVenture2Member2023-06-300000766704well:ReveraJointVentureDisposalTransactionMember2023-06-012023-06-300000766704well:UKPortfolioReveraJointVenture1Member2023-06-012023-06-300000766704well:ReveraJointVentureDisposalTransactionMemberwell:AveryHealthcareMember2023-06-012023-06-300000766704well:ReveraJointVentureDisposalTransactionMember2023-06-300000766704well:ReveraJointVentureAcquisitionTransactionMember2023-07-012023-09-300000766704well:USPortfolioReveraJointVentureMember2023-09-300000766704well:ReveraMemberwell:USPortfolioReveraJointVentureMember2023-09-300000766704well:ReveraJointVentureDisposalTransactionUSPropertiesMember2023-07-012023-09-300000766704well:ReveraJointVentureDisposalTransactionMember2023-07-012023-09-300000766704well:ReveraJointVentureAcquisitionTransactionMember2023-09-300000766704well:ReveraJointVentureDisposalTransactionMember2023-09-300000766704well:ReveraJointVentureDisposalTransactionNowWhollyOwnedPropertiesMemberwell:OakmontManagementGroupMember2023-07-012023-09-300000766704well:ReveraJointVentureDisposalTransactionExistingWhollyOwnedPropertiesMemberwell:OakmontManagementGroupMember2023-07-012023-09-300000766704well:ReveraJointVentureAcquisitionTransactionMember2024-04-012024-04-300000766704well:CanadianPortfolioReveraJointVentureMember2023-09-300000766704well:ReveraJointVentureDisposalTransactionMember2024-04-012024-04-300000766704well:UKPortfolioReveraJointVenture1Member2024-04-012024-04-300000766704well:ReveraJointVentureAcquisitionTransactionMember2024-04-012024-04-010000766704well:CogirSeniorLivingMemberwell:ReveraJointVentureAcquisitionTransactionMember2024-04-012024-04-010000766704well:ReveraJointVentureAcquisitionTransactionMemberwell:LevanteLivingMember2024-04-012024-04-010000766704well:ReveraJointVentureAcquisitionTransactionMemberwell:OptimaLivingMember2024-04-012024-04-010000766704well:ReveraJointVentureDisposalTransactionMember2024-04-300000766704well:GenesisHealthCareOperatingRelationshipMember2021-03-012021-03-310000766704well:GenesisHealthCareOperatingRelationshipMember2021-03-310000766704well:GenesisHealthCareOperatingRelationshipMember2023-03-310000766704well:JointVentureWithAuroraHealthNetworkPeaceCapitalMember2023-05-012023-05-010000766704well:JointVentureWithAuroraHealthNetworkPeaceCapitalMember2023-05-0100007667042023-05-012023-05-010000766704srt:MinimumMember2024-01-012024-06-300000766704srt:MaximumMember2024-01-012024-06-300000766704us-gaap:CostOfSalesMember2024-01-012024-06-300000766704us-gaap:CostOfSalesMember2023-01-012023-06-300000766704us-gaap:GeneralAndAdministrativeExpenseMember2024-01-012024-06-300000766704us-gaap:GeneralAndAdministrativeExpenseMember2023-01-012023-06-300000766704us-gaap:OperatingSegmentsMember2024-06-300000766704us-gaap:OperatingSegmentsMember2023-12-310000766704us-gaap:CorporateNonSegmentMember2023-12-310000766704us-gaap:CorporateNonSegmentMember2024-06-300000766704well:OperatingSegmentsAndCorporateNonSegmentMember2024-06-300000766704well:OperatingSegmentsAndCorporateNonSegmentMember2023-12-310000766704us-gaap:MortgageReceivablesMember2024-06-300000766704us-gaap:MortgageReceivablesMember2023-12-310000766704well:OtherRealEstateLoansReceivablesMember2024-06-300000766704well:OtherRealEstateLoansReceivablesMember2023-12-310000766704us-gaap:RealEstateLoanMember2024-06-300000766704us-gaap:RealEstateLoanMember2023-12-310000766704us-gaap:RealEstateMemberus-gaap:MortgageReceivablesMember2024-06-300000766704us-gaap:RealEstateMemberus-gaap:MortgageReceivablesMember2024-01-012024-06-300000766704well:DeterioratedLoansMember2024-06-300000766704well:CollectiveLoanPool1Member2024-06-300000766704well:CollectiveLoanPool2Member2024-06-300000766704well:CollectiveLoanPool3Member2024-06-300000766704well:CollectiveLoanPool4Member2024-06-300000766704well:CollectiveLoanPool5Member2024-06-300000766704well:CollectiveLoanPool6Member2024-06-300000766704us-gaap:RealEstateLoanMember2024-06-300000766704well:SecuredAndUnsecuredDebtMemberwell:GenesisHealthCareCorporationMember2024-06-300000766704srt:MinimumMemberwell:SeniorsHousingOperatingMember2024-06-300000766704well:SeniorsHousingOperatingMembersrt:MaximumMember2024-06-300000766704well:SeniorsHousingOperatingMember2024-06-300000766704well:SeniorsHousingOperatingMember2023-12-310000766704srt:MinimumMemberwell:TripleNetMember2024-06-300000766704well:TripleNetMembersrt:MaximumMember2024-06-300000766704well:TripleNetMember2024-06-300000766704well:TripleNetMember2023-12-310000766704srt:MinimumMemberwell:OutpatientMedicalMember2024-06-300000766704well:OutpatientMedicalMembersrt:MaximumMember2024-06-300000766704well:OutpatientMedicalMember2024-06-300000766704well:OutpatientMedicalMember2023-12-310000766704us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2024-06-300000766704us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2024-01-012024-06-300000766704well:CogirManagementCorporationMemberwell:NetOperatingingIncomeMemberus-gaap:CreditConcentrationRiskMember2024-06-300000766704well:CogirManagementCorporationMemberwell:NetOperatingingIncomeMemberus-gaap:CreditConcentrationRiskMember2024-01-012024-06-300000766704well:NetOperatingingIncomeMemberwell:IntegraHealthcarePropertiesMemberus-gaap:CreditConcentrationRiskMember2024-06-300000766704well:NetOperatingingIncomeMemberwell:IntegraHealthcarePropertiesMemberus-gaap:CreditConcentrationRiskMember2024-01-012024-06-300000766704well:SunriseSeniorLivingMemberwell:NetOperatingingIncomeMemberus-gaap:CreditConcentrationRiskMember2024-06-300000766704well:SunriseSeniorLivingMemberwell:NetOperatingingIncomeMemberus-gaap:CreditConcentrationRiskMember2024-01-012024-06-300000766704well:AveryHealthcare1Memberwell:NetOperatingingIncomeMemberus-gaap:CreditConcentrationRiskMember2024-06-300000766704well:AveryHealthcare1Memberwell:NetOperatingingIncomeMemberus-gaap:CreditConcentrationRiskMember2024-01-012024-06-300000766704well:NetOperatingingIncomeMemberwell:OakmontManagementGroupMemberus-gaap:CreditConcentrationRiskMember2024-06-300000766704well:NetOperatingingIncomeMemberwell:OakmontManagementGroupMemberus-gaap:CreditConcentrationRiskMember2024-01-012024-06-300000766704well:NetOperatingingIncomeMemberus-gaap:CreditConcentrationRiskMemberwell:RemainingPortfolioMember2024-06-300000766704well:NetOperatingingIncomeMemberus-gaap:CreditConcentrationRiskMemberwell:RemainingPortfolioMember2024-01-012024-06-300000766704well:NetOperatingingIncomeMemberus-gaap:CreditConcentrationRiskMember2024-06-300000766704well:NetOperatingingIncomeMemberus-gaap:CreditConcentrationRiskMember2024-01-012024-06-300000766704well:AtriaSeniorLivingMember2024-04-012024-04-300000766704well:AtriaSeniorLivingMember2024-04-012024-06-300000766704well:AtriaSeniorLivingMemberus-gaap:SubsequentEventMember2024-07-012024-07-300000766704us-gaap:RevolvingCreditFacilityMember2024-06-300000766704well:TermCreditFacilityMember2024-06-300000766704well:TermCreditFacilityCADDenominatedMember2024-06-300000766704well:CreditFacilityTrancheDue2026Memberus-gaap:RevolvingCreditFacilityMember2024-06-300000766704well:CreditFacilityTrancheDue2025Memberus-gaap:RevolvingCreditFacilityMember2024-06-300000766704us-gaap:RevolvingCreditFacilityMember2024-01-012024-06-300000766704well:AccordionfeaturememberMemberus-gaap:RevolvingCreditFacilityMember2024-06-300000766704well:AccordionfeaturememberMemberwell:TermCreditFacilityCADDenominatedMember2024-06-300000766704us-gaap:CommercialPaperMembersrt:MaximumMember2024-01-012024-06-300000766704us-gaap:CommercialPaperMember2024-06-300000766704us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:SubsequentEventMember2024-07-300000766704us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2024-06-300000766704well:CreditFacilityTrancheDueJune2028Memberus-gaap:RevolvingCreditFacilityMemberus-gaap:SubsequentEventMember2024-07-300000766704us-gaap:RevolvingCreditFacilityMemberwell:CreditFacilityTrancheDueJune2029Memberus-gaap:SubsequentEventMember2024-07-300000766704us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:SubsequentEventMember2024-07-012024-07-310000766704us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:SubsequentEventMember2024-07-012024-07-300000766704us-gaap:UnsecuredDebtMember2024-06-300000766704us-gaap:SecuredDebtMember2024-06-300000766704srt:MinimumMemberus-gaap:UnsecuredDebtMember2024-06-300000766704us-gaap:UnsecuredDebtMembersrt:MaximumMember2024-06-300000766704us-gaap:UnsecuredDebtMember2023-06-300000766704well:A295SeniorUnsecuredNotesDue2023Memberus-gaap:UnsecuredDebtMember2024-06-300000766704srt:MinimumMemberus-gaap:SecuredDebtMember2024-06-300000766704us-gaap:SecuredDebtMembersrt:MaximumMember2024-06-300000766704us-gaap:SecuredDebtMember2023-06-300000766704us-gaap:UnsecuredDebtMemberwell:UnsecuredTermCreditFacilityMaturesJuly192023Member2024-06-300000766704us-gaap:UnsecuredDebtMemberwell:TermLoanMember2024-06-300000766704us-gaap:UnsecuredDebtMemberwell:TermLoanMember2024-01-012024-06-300000766704us-gaap:UnsecuredDebtMemberwell:TermLoanMemberus-gaap:SecuredOvernightFinancingRateSofrMember2024-01-012024-06-300000766704us-gaap:UnsecuredDebtMemberus-gaap:SecuredOvernightFinancingRateSofrMemberwell:UnsecuredTermCreditFacilityMaturesJuly192023Member2024-06-300000766704well:CanadianDealerOfferedRateMemberus-gaap:UnsecuredDebtMemberwell:TermLoanMember2024-01-012024-06-300000766704well:CanadianDealerOfferedRateMemberus-gaap:UnsecuredDebtMemberwell:TermLoanMember2024-06-300000766704well:UkDebtDue2028Memberus-gaap:UnsecuredDebtMember2024-06-300000766704us-gaap:UnsecuredDebtMemberwell:A450SeniorUnsecuredNotesDue2034Member2024-06-300000766704us-gaap:UnsecuredDebtMember2023-12-310000766704us-gaap:UnsecuredDebtMember2022-12-310000766704us-gaap:UnsecuredDebtMember2024-01-012024-06-300000766704us-gaap:UnsecuredDebtMember2023-01-012023-06-300000766704us-gaap:UnsecuredDebtMemberwell:A2750SeniorUnsecuredNotesDue2028Member2023-05-310000766704us-gaap:UnsecuredDebtMemberwell:A2750SeniorUnsecuredNotesDue2028Member2024-04-012024-06-300000766704us-gaap:UnsecuredDebtMemberwell:A2750SeniorUnsecuredNotesDue2028Member2024-01-012024-06-300000766704us-gaap:UnsecuredDebtMemberwell:A2750SeniorUnsecuredNotesDue2028Member2023-04-012023-06-300000766704us-gaap:UnsecuredDebtMemberwell:A2750SeniorUnsecuredNotesDue2028Member2023-01-012023-06-300000766704us-gaap:UnsecuredDebtMemberwell:A2750SeniorUnsecuredNotesDue2028Member2024-06-300000766704us-gaap:UnsecuredDebtMemberwell:A2750SeniorUnsecuredNotesDue2028Member2023-12-310000766704us-gaap:UnsecuredDebtMemberwell:A2029ExchangeableNotesMemberus-gaap:SubsequentEventMember2024-07-310000766704us-gaap:SecuredDebtMember2023-12-310000766704us-gaap:SecuredDebtMember2022-12-310000766704us-gaap:SecuredDebtMember2024-01-012024-06-300000766704us-gaap:SecuredDebtMember2023-01-012023-06-300000766704us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-03-310000766704us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-01-012024-01-310000766704us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-01-012024-06-300000766704us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-01-310000766704us-gaap:UnsecuredDebtMemberwell:A2.8SeniorUnsecuredNotesMember2024-06-300000766704us-gaap:InterestRateSwapMember2024-06-300000766704us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMembercurrency:CAD2024-06-300000766704us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMembercurrency:CAD2023-12-310000766704currency:GBPus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-06-300000766704currency:GBPus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-12-310000766704us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMembercurrency:CAD2024-01-012024-06-300000766704us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMembercurrency:CAD2023-01-012023-12-310000766704currency:GBPus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-01-012024-06-300000766704currency:GBPus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-01-012023-12-310000766704currency:USDus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-06-300000766704currency:USDus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-12-310000766704currency:USDus-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-06-300000766704currency:USDus-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-12-310000766704us-gaap:NondesignatedMemberus-gaap:ForwardContractsMembercurrency:CAD2024-06-300000766704us-gaap:NondesignatedMemberus-gaap:ForwardContractsMembercurrency:CAD2023-12-310000766704us-gaap:DesignatedAsHedgingInstrumentMember2024-04-012024-06-300000766704us-gaap:DesignatedAsHedgingInstrumentMember2023-04-012023-06-300000766704us-gaap:DesignatedAsHedgingInstrumentMember2024-01-012024-06-300000766704us-gaap:DesignatedAsHedgingInstrumentMember2023-01-012023-06-300000766704us-gaap:NondesignatedMember2024-04-012024-06-300000766704us-gaap:NondesignatedMember2023-04-012023-06-300000766704us-gaap:NondesignatedMember2024-01-012024-06-300000766704us-gaap:NondesignatedMember2023-01-012023-06-300000766704us-gaap:WarrantMember2024-04-012024-06-300000766704us-gaap:WarrantMember2023-04-012023-06-300000766704us-gaap:WarrantMember2024-01-012024-06-300000766704us-gaap:WarrantMember2023-01-012023-06-300000766704us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherComprehensiveIncomeMember2024-04-012024-06-300000766704us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherComprehensiveIncomeMember2023-04-012023-06-300000766704us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherComprehensiveIncomeMember2024-01-012024-06-300000766704us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherComprehensiveIncomeMember2023-01-012023-06-300000766704well:SeniorsHousingOperatingPropertiesAffinityBrandMember2024-06-300000766704well:AtTheMarketProgramMember2024-04-300000766704well:AtTheMarketProgramMember2024-02-150000766704well:AtTheMarketProgramMember2024-06-300000766704well:AtTheMarketProgramMemberus-gaap:SubsequentEventMember2024-07-012024-07-300000766704well:AtTheMarketProgramMember2023-01-012023-06-300000766704well:AtTheMarketProgramMember2023-06-300000766704well:AtTheMarketProgramMember2024-01-012024-06-300000766704us-gaap:SubsequentEventMember2024-07-292024-07-290000766704us-gaap:AccumulatedTranslationAdjustmentMember2024-06-300000766704us-gaap:AccumulatedTranslationAdjustmentMember2023-12-310000766704us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-06-300000766704us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-12-3100007667042022-03-310000766704us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:MortgagesMember2024-06-300000766704us-gaap:MortgagesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2024-06-300000766704us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:MortgagesMember2023-12-310000766704us-gaap:MortgagesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310000766704us-gaap:CarryingReportedAmountFairValueDisclosureMemberwell:OtherRealEstateLoansReceivableMember2024-06-300000766704us-gaap:EstimateOfFairValueFairValueDisclosureMemberwell:OtherRealEstateLoansReceivableMember2024-06-300000766704us-gaap:CarryingReportedAmountFairValueDisclosureMemberwell:OtherRealEstateLoansReceivableMember2023-12-310000766704us-gaap:EstimateOfFairValueFairValueDisclosureMemberwell:OtherRealEstateLoansReceivableMember2023-12-310000766704us-gaap:CarryingReportedAmountFairValueDisclosureMember2024-06-300000766704us-gaap:EstimateOfFairValueFairValueDisclosureMember2024-06-300000766704us-gaap:CarryingReportedAmountFairValueDisclosureMember2023-12-310000766704us-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310000766704us-gaap:CarryingReportedAmountFairValueDisclosureMemberwell:NonRealEstateLoansReceivablesMember2024-06-300000766704us-gaap:EstimateOfFairValueFairValueDisclosureMemberwell:NonRealEstateLoansReceivablesMember2024-06-300000766704us-gaap:CarryingReportedAmountFairValueDisclosureMemberwell:NonRealEstateLoansReceivablesMember2023-12-310000766704us-gaap:EstimateOfFairValueFairValueDisclosureMemberwell:NonRealEstateLoansReceivablesMember2023-12-310000766704us-gaap:FairValueInputsLevel1Member2024-06-300000766704us-gaap:FairValueInputsLevel2Member2024-06-300000766704us-gaap:FairValueInputsLevel3Member2024-06-300000766704us-gaap:WarrantMember2023-12-310000766704us-gaap:WarrantMember2022-12-310000766704us-gaap:WarrantMember2024-01-012024-06-300000766704us-gaap:WarrantMember2023-01-012023-06-300000766704us-gaap:WarrantMember2024-06-300000766704us-gaap:WarrantMember2023-06-300000766704well:TerminalCapitalizationRateMember2024-06-300000766704well:TerminalCapitalizationRateMember2023-06-300000766704us-gaap:OperatingSegmentsMemberwell:SeniorHousingOperatingMember2024-04-012024-06-300000766704us-gaap:OperatingSegmentsMemberwell:TripleNetMember2024-04-012024-06-300000766704us-gaap:OperatingSegmentsMemberwell:OutpatientMedicalMember2024-04-012024-06-300000766704us-gaap:CorporateNonSegmentMember2024-04-012024-06-300000766704us-gaap:OperatingSegmentsMemberwell:SeniorHousingOperatingMember2024-06-300000766704us-gaap:OperatingSegmentsMemberwell:TripleNetMember2024-06-300000766704us-gaap:OperatingSegmentsMemberwell:OutpatientMedicalMember2024-06-300000766704us-gaap:OperatingSegmentsMemberwell:SeniorHousingOperatingMember2023-04-012023-06-300000766704us-gaap:OperatingSegmentsMemberwell:TripleNetMember2023-04-012023-06-300000766704us-gaap:OperatingSegmentsMemberwell:OutpatientMedicalMember2023-04-012023-06-300000766704us-gaap:CorporateNonSegmentMember2023-04-012023-06-300000766704us-gaap:OperatingSegmentsMemberwell:SeniorHousingOperatingMember2024-01-012024-06-300000766704us-gaap:OperatingSegmentsMemberwell:TripleNetMember2024-01-012024-06-300000766704us-gaap:OperatingSegmentsMemberwell:OutpatientMedicalMember2024-01-012024-06-300000766704us-gaap:CorporateNonSegmentMember2024-01-012024-06-300000766704us-gaap:OperatingSegmentsMemberwell:SeniorHousingOperatingMember2023-01-012023-06-300000766704us-gaap:OperatingSegmentsMemberwell:TripleNetMember2023-01-012023-06-300000766704us-gaap:OperatingSegmentsMemberwell:OutpatientMedicalMember2023-01-012023-06-300000766704us-gaap:CorporateNonSegmentMember2023-01-012023-06-300000766704country:US2024-04-012024-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:USus-gaap:SalesRevenueNetMember2024-04-012024-06-300000766704country:US2023-04-012023-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:USus-gaap:SalesRevenueNetMember2023-04-012023-06-300000766704country:US2024-01-012024-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:USus-gaap:SalesRevenueNetMember2024-01-012024-06-300000766704country:US2023-01-012023-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:USus-gaap:SalesRevenueNetMember2023-01-012023-06-300000766704country:GB2024-04-012024-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:GBus-gaap:SalesRevenueNetMember2024-04-012024-06-300000766704country:GB2023-04-012023-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:GBus-gaap:SalesRevenueNetMember2023-04-012023-06-300000766704country:GB2024-01-012024-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:GBus-gaap:SalesRevenueNetMember2024-01-012024-06-300000766704country:GB2023-01-012023-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:GBus-gaap:SalesRevenueNetMember2023-01-012023-06-300000766704country:CA2024-04-012024-06-300000766704country:CAus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-04-012024-06-300000766704country:CA2023-04-012023-06-300000766704country:CAus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-04-012023-06-300000766704country:CA2024-01-012024-06-300000766704country:CAus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-01-012024-06-300000766704country:CA2023-01-012023-06-300000766704country:CAus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-012023-06-300000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-04-012024-06-300000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-04-012023-06-300000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-01-012024-06-300000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-012023-06-300000766704country:USus-gaap:ManagementServiceMember2024-04-012024-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:USus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2024-04-012024-06-300000766704country:USus-gaap:ManagementServiceMember2023-04-012023-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:USus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2023-04-012023-06-300000766704country:USus-gaap:ManagementServiceMember2024-01-012024-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:USus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2024-01-012024-06-300000766704country:USus-gaap:ManagementServiceMember2023-01-012023-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:USus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2023-01-012023-06-300000766704country:GBus-gaap:ManagementServiceMember2024-04-012024-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:GBus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2024-04-012024-06-300000766704country:GBus-gaap:ManagementServiceMember2023-04-012023-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:GBus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2023-04-012023-06-300000766704country:GBus-gaap:ManagementServiceMember2024-01-012024-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:GBus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2024-01-012024-06-300000766704country:GBus-gaap:ManagementServiceMember2023-01-012023-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:GBus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2023-01-012023-06-300000766704country:CAus-gaap:ManagementServiceMember2024-04-012024-06-300000766704country:CAus-gaap:GeographicConcentrationRiskMemberus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2024-04-012024-06-300000766704country:CAus-gaap:ManagementServiceMember2023-04-012023-06-300000766704country:CAus-gaap:GeographicConcentrationRiskMemberus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2023-04-012023-06-300000766704country:CAus-gaap:ManagementServiceMember2024-01-012024-06-300000766704country:CAus-gaap:GeographicConcentrationRiskMemberus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2024-01-012024-06-300000766704country:CAus-gaap:ManagementServiceMember2023-01-012023-06-300000766704country:CAus-gaap:GeographicConcentrationRiskMemberus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2023-01-012023-06-300000766704us-gaap:ManagementServiceMember2024-04-012024-06-300000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2024-04-012024-06-300000766704us-gaap:ManagementServiceMember2023-04-012023-06-300000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2023-04-012023-06-300000766704us-gaap:ManagementServiceMember2024-01-012024-06-300000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2024-01-012024-06-300000766704us-gaap:ManagementServiceMember2023-01-012023-06-300000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2023-01-012023-06-300000766704country:US2024-06-300000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:AssetsTotalMembercountry:US2024-01-012024-06-300000766704country:US2023-12-310000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:AssetsTotalMembercountry:US2023-01-012023-12-310000766704country:GB2024-06-300000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:AssetsTotalMembercountry:GB2024-01-012024-06-300000766704country:GB2023-12-310000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:AssetsTotalMembercountry:GB2023-01-012023-12-310000766704country:CA2024-06-300000766704country:CAus-gaap:GeographicConcentrationRiskMemberus-gaap:AssetsTotalMember2024-01-012024-06-300000766704country:CA2023-12-310000766704country:CAus-gaap:GeographicConcentrationRiskMemberus-gaap:AssetsTotalMember2023-01-012023-12-310000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:AssetsTotalMember2024-01-012024-06-300000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:AssetsTotalMember2023-01-012023-12-310000766704us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2024-06-300000766704us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2023-12-310000766704us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2024-04-012024-06-300000766704us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2024-01-012024-06-300000766704us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2023-04-012023-06-300000766704us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2023-01-012023-06-30


UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
 QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2024
or
 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                     to                      
Commission file number: 1-8923
WELLTOWER INC.
 
(Exact name of registrant as specified in its charter
Delaware
34-1096634
(State or other jurisdiction
of Incorporation)
(IRS Employer
Identification No.)
4500 Dorr StreetToledo,Ohio43615
(Address of principal executive office)(Zip Code)
(419) -247-2800
(Registrant’s telephone number, including area code)  
Not Applicable
(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common stock, $1.00 par value per shareWELLNew York Stock Exchange
Guarantee of 4.800% Notes due 2028 issued by Welltower OP LLCWELL/28New York Stock Exchange
Guarantee of 4.500% Notes due 2034 issued by Welltower OP LLCWELL/34New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  þ  No  ¨
Indicate by check mark whether the registrant has submitted electronically, if any, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes þ  No  ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
 þ
 Accelerated filer
¨
 Non-accelerated filer
¨
 Smaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No  þ
As of July 26, 2024, Welltower Inc. had 609,147,531 shares of common stock outstanding.





TABLE OF CONTENTS
 
 
PART I. FINANCIAL INFORMATIONPage
Item 1. Financial Statements (Unaudited)
Consolidated Balance Sheets
Consolidated Statements of Comprehensive Income
Consolidated Statements of Equity
Consolidated Statements of Cash Flows
Notes to Unaudited Consolidated Financial Statements
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Item 4. Controls and Procedures
PART II. OTHER INFORMATION 
Item 1. Legal Proceedings
Item 1A. Risk Factors
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Item 5. Other Information
Item 6. Exhibits
Signatures



PART I. FINANCIAL INFORMATION

CONSOLIDATED BALANCE SHEETS
WELLTOWER INC. AND SUBSIDIARIES
(In thousands) 
June 30, 2024 (Unaudited)December 31, 2023 (Note)
Assets:  
  
Real estate investments:  
  
Real property owned:  
Land and land improvements  $4,839,036 $4,697,824 
Buildings and improvements  38,540,623 37,796,553 
Acquired lease intangibles  2,192,386 2,166,470 
Real property held for sale, net of accumulated depreciation  81,033 372,883 
Construction in progress  1,474,024 1,304,441 
Less accumulated depreciation and amortization  (9,908,007)(9,274,814)
Net real property owned  37,219,095 37,063,357 
Right of use assets, net360,282 350,969 
Real estate loans receivable, net of credit allowance  1,791,202 1,361,587 
Net real estate investments  39,370,579 38,775,913 
Other assets:  
Investments in unconsolidated entities  1,709,558 1,636,531 
Goodwill  68,321 68,321 
Cash and cash equivalents  2,776,628 1,993,646 
Restricted cash  86,970 82,437 
Straight-line rent receivable420,666 443,800 
Receivables and other assets  1,101,215 1,011,518 
Total other assets  6,163,358 5,236,253 
Total assets  
$45,533,937 $44,012,166 
Liabilities and equity  
Liabilities:  
Unsecured credit facility and commercial paper$ $ 
Senior unsecured notes  12,169,775 13,552,222 
Secured debt  1,765,992 2,183,327 
Lease liabilities393,670 383,230 
Accrued expenses and other liabilities  1,515,921 1,521,660 
Total liabilities  
15,845,358 17,640,439 
Redeemable noncontrolling interests  
262,273 290,605 
Equity:  
Common stock  609,859 565,894 
Capital in excess of par value  36,693,283 32,741,949 
Treasury stock  (114,674)(111,578)
Cumulative net income  9,526,904 9,145,044 
Cumulative dividends  (17,492,484)(16,773,773)
Accumulated other comprehensive income (loss)  (246,462)(163,160)
Total Welltower Inc. stockholders' equity  28,976,426 25,404,376 
Noncontrolling interests  449,880 676,746 
Total equity  
29,426,306 26,081,122 
Total liabilities and equity  
$45,533,937 $44,012,166 
Note: The consolidated balance sheet at December 31, 2023 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by U.S. generally accepted accounting principles for complete financial statements.

3


CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)
WELLTOWER INC. AND SUBSIDIARIES
(In thousands, except per share data) 
Three Months EndedSix Months Ended
June 30,June 30,
 2024202320242023
Revenues:  
Resident fees and services$1,393,473  $1,159,449 $2,753,747 $2,291,134 
Rental income  335,811 383,439 753,463 767,498 
Interest income63,453 38,710 116,117 75,115 
Other income32,147 83,880 61,298 92,460 
Total revenues1,824,884 1,665,478 3,684,625 3,226,207 
Expenses:
Property operating expenses1,111,297 958,672 2,208,210 1,916,425 
Depreciation and amortization382,045 341,945 747,908 681,057 
Interest expense133,424 152,337 280,742 296,740 
General and administrative expenses55,565 44,287 108,883 88,658 
Loss (gain) on derivatives and financial instruments, net(5,825)1,280 (8,879)2,210 
Loss (gain) on extinguishment of debt, net1,705 1 1,711 6 
Provision for loan losses, net5,163 2,456 6,177 3,233 
Impairment of assets2,394 1,086 45,725 13,715 
Other expenses48,684 11,069 62,815 33,814 
Total expenses1,734,452 1,513,133 3,453,292 3,035,858 
Income (loss) from continuing operations before income taxes and other items90,432 152,345 231,333 190,349 
Income tax (expense) benefit(1,101)(3,503)(7,292)(6,548)
Income (loss) from unconsolidated entities4,896 (40,332)(2,887)(47,403)
Gain (loss) on real estate dispositions, net166,443 (2,168)171,150 (1,421)
Income (loss) from continuing operations260,670 106,342 392,304 134,977 
Net income (loss)260,670 106,342 392,304 134,977 
Less: Net income (loss) attributable to noncontrolling interests(1)
5,956 3,302 10,444 6,264 
Net income (loss) attributable to common stockholders$254,714 $103,040 $381,860 $128,713 
Weighted average number of common shares outstanding:
Basic600,545 499,023 587,297 495,561 
Diluted604,563 501,970 591,047 498,305 
Earnings per share:
Basic:
Income (loss) from continuing operations$0.43 $0.21 $0.67 $0.27 
Net income (loss) attributable to common stockholders$0.42 $0.21 $0.65 $0.26 
Diluted:
Income (loss) from continuing operations$0.43 $0.21 $0.66 $0.27 
Net income (loss) attributable to common stockholders(2)
$0.42 $0.20 $0.65 $0.26 
Dividends declared and paid per common share(3)
$0.61 $0.61 $1.22 $1.22 
(1) Includes amounts attributable to redeemable noncontrolling interests.
(2) Includes adjustment to the numerator for income (loss) attributable to OP Units and DownREIT Units.
(3) In June, the Board approved to increase the dividend to $0.67 beginning in the third quarter.

4


CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)
WELLTOWER INC. AND SUBSIDIARIES
(In thousands) 
 Three Months EndedSix Months Ended
June 30,June 30,
 2024202320242023
Net income (loss)$260,670 $106,342 $392,304 $134,977 
Other comprehensive income (loss):
Foreign currency translation gain (loss)(28,340)119,519 (114,170)200,284 
Derivative and financial instruments designated as hedges gain (loss)9,096 (85,884)69,711 (155,622)
Total other comprehensive income (loss)(19,244)33,635 (44,459)44,662 
Total comprehensive income (loss)241,426 139,977 347,845 179,639 
Less: Total comprehensive income (loss) attributable
to noncontrolling interests(1)
5,258 8,286 2,208 14,127 
Total comprehensive income (loss) attributable to common stockholders$236,168 $131,691 $345,637 $165,512 
(1) Includes amounts attributable to redeemable noncontrolling interests.

5


CONSOLIDATED STATEMENTS OF EQUITY (UNAUDITED)
WELLTOWER INC. AND SUBSIDIARIES
(In thousands)
Six Months Ended June 30, 2024
Common StockCapital in
Excess of
Par Value
Treasury
Stock
Cumulative
Net Income
Cumulative
Dividends
Accumulated Other
Comprehensive
Income (Loss)
Noncontrolling
Interests
Total
Balances at January 1, 2024
$565,894 $32,741,949 $(111,578)$9,145,044 $(16,773,773)$(163,160)$676,746 $26,081,122 
Comprehensive income:
Net income (loss)   127,146   4,180 131,326 
Other comprehensive income (loss)    (17,677)(6,075)(23,752)
Total comprehensive income       107,574 
Net change in noncontrolling interests (19,282)    6,191 (13,091)
Adjustment to members' interest from change in ownership in Welltower OP (18,852)    18,852  
Redemption of OP Units and DownREIT Units19 825    (844) 
Amounts related to stock incentive plans, net of forfeitures112 11,936 (3,264)    8,784 
Net proceeds from issuance of common stock26,612 2,388,521      2,415,133 
Dividends paid:
Common stock dividends    (352,529)  (352,529)
Balances at March 31, 2024
$592,637 $35,105,097 $(114,842)$9,272,190 $(17,126,302)$(180,837)$699,050 $28,246,993 
Comprehensive income:
Net income (loss)254,714 5,806 260,520 
Other comprehensive income (loss)(18,656)(95)(18,751)
Total comprehensive income241,769 
Net change in noncontrolling interests(49,943)(46,969)(256,613)(353,525)
Adjustment to members' interest from change in ownership in Welltower OP(1,833)1,833  
Redemption of OP Units and DownREIT Units476 42,636 (101)43,011 
Amounts related to stock incentive plans, net of forfeitures36 11,028 168 11,232 
Net proceeds from issuance of common stock16,710 1,586,298 1,603,008 
Dividends paid:
Common stock dividends(366,182)(366,182)
Balances at June 30, 2024
$609,859 $36,693,283 $(114,674)$9,526,904 $(17,492,484)$(246,462)$449,880 $29,426,306 


6


CONSOLIDATED STATEMENTS OF EQUITY (UNAUDITED)
WELLTOWER INC. AND SUBSIDIARIES
(In thousands)
 Six Months Ended June 30, 2023
 Common StockCapital in
Excess of
Par Value
Treasury
Stock
Cumulative
Net Income
Cumulative
Dividends
Accumulated Other
Comprehensive
Income (Loss)
Noncontrolling
Interests
Total
Balances at January 1, 2023
$491,919 $26,742,750 $(111,001)$8,804,950 $(15,514,097)$(119,707)$714,739 $21,009,553 
Comprehensive income:
Net income (loss)25,673 2,688 28,361 
Other comprehensive income (loss)8,148 3,023 11,171 
Total comprehensive income39,532 
Net change in noncontrolling interests(8,304)29,648 21,344 
Adjustment to members' interest from change in ownership in Welltower OP(6,139)6,139  
Redemption of OP Units and DownREIT Units272 17,515 (432)17,355 
Amounts related to stock incentive plans, net of forfeitures134 9,330 (1,924)7,540 
Net proceeds from issuance of common stock5,603 404,862 410,465 
Dividends paid:
Common stock dividends(301,829)(301,829)
Balances at March 31, 2023
$497,928 $27,160,014 $(112,925)$8,830,623 $(15,815,926)$(111,559)$755,805 $21,203,960 
Comprehensive income:
Net income (loss)103,040 3,505 106,545 
Other comprehensive income (loss)28,651 4,410 33,061 
Total comprehensive income139,606 
Net change in noncontrolling interests8,579 (12,686)(149,013)(153,120)
Adjustment to members' interest from change in ownership in Welltower OP(4,794)4,794  
Redemption of OP Units and DownREIT Units1 18 (19) 
Amounts related to stock incentive plans, net of forfeitures43 11,088 893 12,024 
Net proceeds from issuance of common stock11,833 910,392 922,225 
Dividends paid:
Common stock dividends(300,772)(300,772)
Balances at June 30, 2023
$509,805 $28,085,297 $(112,032)$8,933,663 $(16,116,698)$(95,594)$619,482 $21,823,923 

7


CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
WELLTOWER INC. AND SUBSIDIARIES
(In thousands)
Six Months Ended
June 30,
 20242023
Operating activities:    
Net income  $392,304 $134,977 
Adjustments to reconcile net income to net cash provided from (used in) operating activities:  
Depreciation and amortization  
747,908 681,057 
Other amortization expenses  
28,106 20,086 
Provision for loan losses, net6,177 3,233 
Impairment of assets  
45,725 13,715 
Stock-based compensation expense  
22,398 19,960 
Loss (gain) on derivatives and financial instruments, net  
(8,879)2,210 
Loss (gain) on extinguishment of debt, net  
1,711 6 
Loss (income) from unconsolidated entities
2,887 47,403 
Rental income less than (in excess of) cash received  
13,696 (71,997)
Amortization related to above (below) market leases, net  
14 (248)
Loss (gain) on real estate dispositions, net  (171,150)1,421 
Proceeds from (payments on) interest rate swap settlements(59,555)(65,485)
Distributions by unconsolidated entities
10,018 6,895 
Increase (decrease) in accrued expenses and other liabilities  
53,105 (9,380)
Decrease (increase) in receivables and other assets  
(72,240)8,450 
Net cash provided from (used in) operating activities  1,012,225 792,303 
 
Investing activities:  
Cash disbursed for acquisitions, net of cash acquired
(607,527)(424,094)
Cash disbursed for capital improvements to existing properties
(297,602)(204,978)
Cash disbursed for construction in progress
(459,122)(474,115)
Capitalized interest  
(28,287)(22,205)
Investment in loans receivable
(580,145)(76,397)
Principal collected on loans receivable  
138,059 46,493 
Other investments, net of payments  
(37,185)(95,819)
Contributions to unconsolidated entities  
(146,196)(206,160)
Distributions by unconsolidated entities  
21,859 125,176 
Net proceeds from net investment hedge settlements6,631 3,933 
Proceeds from sales of real property  
129,773 1,950 
Net cash provided from (used in) investing activities  (1,859,742)(1,326,216)
Financing activities:  
Net increase (decrease) under unsecured credit facility and commercial paper
  
Net proceeds from issuance of senior unsecured notes 1,011,427 
Payments to extinguish senior unsecured notes  
(1,350,000) 
Net proceeds from the issuance of secured debt  
2,872 373,462 
Payments on secured debt  
(233,799)(101,277)
Net proceeds from the issuance of common stock  
4,020,345 1,333,908 
Payments for deferred financing costs and prepayment penalties  
(6)(6,958)
Contributions by noncontrolling interests(1)
26,569 181,272 
Distributions to noncontrolling interests(1)
(85,803)(80,672)
Cash distributions to stockholders  
(718,278)(603,597)
Other financing activities
(24,215)(5,254)
Net cash provided from (used in) financing activities  1,637,685 2,102,311 
Effect of foreign currency translation on cash and cash equivalents and restricted cash(2,653)8,379 
Increase (decrease) in cash, cash equivalents and restricted cash  787,515 1,576,777 
Cash, cash equivalents and restricted cash at beginning of period  2,076,083 722,292 
Cash, cash equivalents and restricted cash at end of period  $2,863,598 $2,299,069 
Supplemental cash flow information:
Interest paid$280,277 $273,979 
Income taxes paid (received), net9,125 1,157 
(1) Includes amounts attributable to redeemable noncontrolling interests.

8

WELLTOWER INC. AND SUBSIDIARIES
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

1. Business
Welltower Inc., an S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. We invest with leading seniors housing operators, post-acute providers and health systems to fund the real estate and infrastructure needed to scale innovative care delivery models and improve people's wellness and overall health care experience. Welltower Inc., a real estate investment trust ("REIT"), owns interests in properties concentrated in major, high-growth markets in the United States ("U.S."), Canada and the United Kingdom ("U.K."), consisting of seniors housing and post-acute communities and outpatient medical properties. 
We are structured as an umbrella partnership REIT under which substantially all of our business is conducted through Welltower OP LLC, the day-to-day management of which is exclusively controlled by Welltower Inc. Unless stated otherwise or the context otherwise requires, references to "Welltower" mean Welltower Inc. and references to "Welltower OP" mean Welltower OP LLC. References to "we," "us" and "our" mean collectively Welltower, Welltower OP and those entities/subsidiaries owned or controlled by Welltower and/or Welltower OP. Welltower's weighted average ownership in Welltower OP was 99.737% for the six months ended June 30, 2024. As of June 30, 2024, Welltower owned 99.730% of the issued and outstanding units of Welltower OP, with other investors owning the remaining 0.270% of outstanding units. We adjust the noncontrolling members' interest at the end of each period to reflect their interest in the net assets of Welltower OP.
2. Accounting Policies and Related Matters
Basis of Presentation
The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles ("U.S. GAAP") for interim financial information and with instructions to Quarterly Report on Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (such as normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the six months ended June 30, 2024 are not necessarily an indication of the results that may be expected for the year ending December 31, 2024. For further information, refer to the financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2023.
New Accounting Standards   
In November 2023, the FASB issued Accounting Standards Update No. 2023-07, "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures," which is intended to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The guidance is to be applied retrospectively to all periods presented in the financial statements. We are currently evaluating the potential impact of adopting this new guidance on our consolidated financial statements and disclosures.
In December 2023, the FASB issued Accounting Standards Update No. 2023-09, "Income Taxes (Topic 740): Improvements to Income Tax Disclosures ("ASU 2023-09")," which modifies the rules on income tax disclosures to require entities to disclose (1) specific categories in the rate reconciliation, (2) the income or loss from continuing operations before income tax expense or benefit (separated between domestic and foreign) and (3) income tax expense or benefit from continuing operations (separated by federal, state and foreign). ASU 2023-09 also requires entities to disclose their income tax payments to international, federal, state and local jurisdictions, among other changes. The guidance is effective for annual periods beginning after December 15, 2024. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. ASU 2023-09 should be applied on a prospective basis, but retrospective application is permitted. We are currently evaluating the potential impact of adopting this new guidance on our consolidated financial statements and disclosures.
3. Real Property Acquisitions and Development 
The total purchase price for all properties acquired has been allocated to the tangible and identifiable intangible assets and liabilities at cost on a relative fair value basis. Liabilities assumed and any associated noncontrolling interests are reflected at fair value. The results of operations for these acquisitions have been included in our consolidated results of operations since the date of acquisition and are a component of the appropriate segments. Transaction costs primarily represent costs incurred with acquisitions, including due diligence costs, fees for legal and valuation services, termination of pre-existing relationships computed based on the fair value of the assets acquired, lease termination fees and other acquisition-related costs. Transaction costs directly related to asset acquisitions are capitalized as a component of purchase price and all other non-capitalizable costs are reflected in other expenses on our Consolidated Statements of Comprehensive Income. Our acquisition of properties are at times subject to earn out provisions based on the future operating performance of the acquired properties, which could result in incremental payments in the future. Our policy is to recognize such contingent consideration when the contingency is resolved and the consideration becomes payable.

9

WELLTOWER INC. AND SUBSIDIARIES
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
The following is a summary of our real property investment activity by segment for the periods presented (in thousands):
 Six Months Ended
 June 30, 2024June 30, 2023
Seniors Housing OperatingTriple-netOutpatient
Medical
TotalsSeniors Housing OperatingTriple-netOutpatient
Medical
Totals
Land and land improvements$68,662 $14,193 $10,160 $93,015 $4,426 $7,370 $60,527 $72,323 
Buildings and improvements422,488 61,914 33,064 517,466 50,172 74,289 256,190 380,651 
Acquired lease intangibles34,827  2,193 37,020 970  39,090 40,060 
Construction in progress19,397   19,397     
Right of use assets, net      927 927 
Total net real estate assets545,374 76,107 45,417 666,898 55,568 81,659 356,734 493,961 
Receivables and other assets1,403 34 112 1,549 2,089  358 2,447 
Total assets acquired546,777 76,141 45,529 668,447 57,657 81,659 357,092 496,408 
Secured debt    (21,767) (40,953)(62,720)
Lease liabilities      (953)(953)
Accrued expenses and other liabilities(11,905) (182)(12,087)(570) (8,071)(8,641)
Total liabilities acquired(11,905) (182)(12,087)(22,337) (49,977)(72,314)
Noncontrolling interests(1,149)  (1,149)    
Non-cash acquisition related activity(1)
(46,974)(710) (47,684)    
Cash disbursed for acquisitions486,749 75,431 45,347 607,527 35,320 81,659 307,115 424,094 
Construction in progress additions317,468 28 182,290 499,786 295,120 25,646 190,164 510,930 
Less: Capitalized interest(23,712) (4,575)(28,287)(16,761)(2,416)(3,028)(22,205)
Accruals (2)
474 126 (12,977)(12,377)746 (9,384)(5,972)(14,610)
Cash disbursed for construction in progress294,230 154 164,738 459,122 279,105 13,846 181,164 474,115 
Capital improvements to existing properties239,484 11,706 46,412 297,602 165,187 11,784 28,007 204,978 
Total cash invested in real property, net of cash acquired$1,020,463 $87,291 $256,497 $1,364,251 $479,612 $107,289 $516,286 $1,103,187 
(1) Primarily relates to the acquisition of assets previously financed as real estate loans receivable and the acquisition of assets previously recognized as investments in unconsolidated entities.
(2) Represents non-cash accruals for amounts to be paid in future periods for properties that converted, offset by amounts paid in the current period.
Announced Acquisitions
In February 2024, we entered into a definitive agreement to acquire 25 Seniors Housing Operating properties for a total purchase price of $969 million, which will be managed under the Affinity brand. The transaction is expected to close in the second half of 2024 and will be funded through a combination of cash and the expected assumption of approximately $521 million of secured debt, subject to customary closing conditions and lender consents.
In July 2024, we entered into a definitive agreement to acquire a seniors housing portfolio for approximately $0.9 billion. The transaction is expected to close later in the year, subject to customary closing conditions.
Construction Activity 
The following is a summary of the construction projects that were placed into service and began generating revenues during the periods presented (in thousands):
 Six Months Ended
 June 30, 2024June 30, 2023
Development projects:
Seniors Housing Operating
$194,012 $140,865 
Triple-net
 141,142 
Outpatient Medical
106,596 21,173 
Total development projects
300,608 303,180 
Expansion projects
20,229 26,125 
Total construction in progress conversions$320,837 $329,305 
10

WELLTOWER INC. AND SUBSIDIARIES
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
4. Real Estate Intangibles 
The following is a summary of our real estate intangibles, excluding those related to ground leases or classified as held for sale, as of the dates indicated (dollars in thousands):
 June 30, 2024December 31, 2023
Assets:
In place lease intangibles$2,016,507 $2,001,827 
Above market tenant leases66,663 66,663 
Lease commissions109,216 97,980 
Gross historical cost2,192,386 2,166,470 
Accumulated amortization(1,743,005)(1,651,656)
Net book value$449,381 $514,814 
Liabilities:
Below market tenant leases$70,364 $70,364 
Accumulated amortization(50,325)(47,939)
Net book value$20,039 $22,425 
The following is a summary of real estate intangible amortization income (expense) for the periods presented (in thousands):
Three Months Ended June 30,Six Months Ended June 30,
2024202320242023
Rental income related to (above)/below market tenant leases, net$(54)$130 $(85)$175 
Amortization related to in place lease intangibles and lease commissions(60,876)(53,774)(107,667)(109,925)
5. Dispositions, Real Property Held for Sale and Impairment
We periodically sell properties for various reasons, including favorable market conditions, the exercise of tenant purchase options or reduction of concentrations (i.e., property type, relationship or geography). At June 30, 2024, eight Seniors Housing Operating properties and one Outpatient Medical property with an aggregate real estate balance of $81,033,000 were classified as held for sale. Expected gross sales proceeds related to these held for sale properties are approximately $95,250,000.
During the six months ended June 30, 2024, we recorded impairment charges of $41,157,000 related to nine Seniors Housing Operating properties which were disposed of or classified as held for sale for which the carrying value exceeded the estimated fair value less costs to sell and $4,568,000 related to two Seniors Housing Operating properties and one Triple-net property classified as held for use for which the carrying value exceeded the estimated fair value.
During the six months ended June 30, 2023, we recorded $13,715,000 of impairment charges related to two Seniors Housing Operating properties and one Triple-net property classified as held for sale for which the carrying value exceeded the estimated fair value less costs to sell, and one Seniors Housing Operating property classified as held for use for which the carrying value exceeded the estimated fair value.
Operating results attributable to properties sold or classified as held for sale which do not meet the definition of discontinued operations are not reclassified on our Consolidated Statements of Comprehensive Income. We recognized income (loss) from continuing operations before income taxes and other items from properties sold or classified as held for sale as of June 30, 2024 of $(9,271,000) and $(47,058,000) for the three and six months ended June 30, 2024 and $61,899,000 and $46,849,000 for the same periods in 2023, respectively.
The following is a summary of our real property disposition activity for the periods presented (in thousands):
 Six Months Ended
 June 30, 2024June 30, 2023
Real estate dispositions:(1)
Seniors Housing Operating$353,290 $243,695 
Triple-net
170 2,028 
Outpatient Medical
39,567  
Total dispositions
393,027 245,723 
Gain (loss) on real estate dispositions, net171,150 (1,421)
Net other assets/(liabilities) disposed(78)(624)
 Non-cash consideration (434,326)(241,728)
Cash proceeds from real estate dispositions$129,773 $1,950 
(1) During the six months ended June 30, 2024, includes the disposition of unconsolidated equity method investments that owned six Seniors Housing Operating properties and one Outpatient Medical property.
11

WELLTOWER INC. AND SUBSIDIARIES
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
Strategic Dissolution of Revera Joint Ventures
During the quarter ended June 30, 2023, we entered into definitive agreements to dissolve our existing Revera joint venture relationships across the U.S., U.K. and Canada. The transactions included acquiring the remaining interests in 110 properties from Revera, while simultaneously selling interests in 31 properties to Revera.
In June 2023, we closed the U.K. portfolio portion of the transaction through the acquisition of the remaining ownership interest in 29 properties previously held in two separate consolidated joint venture structures in which we owned 75% and 90% of the interests in exchange for the disposition to Revera of our interests in four properties. In addition, we received cash from Revera of $107,341,000 relating to the net settlement of loans previously made to the joint ventures. Operations for the 29 retained properties were transitioned to Avery Healthcare.
Total proceeds related to the four properties disposed were $222,521,000, which included non-cash consideration from Revera of $241,728,000, comprised of the fair value of interests received by us of $198,837,000 and an allocation of Revera's noncontrolling interests of $42,891,000, partially offset by $9,049,000 of transaction-related expenses as well as the $10,158,000 of cash paid to equalize the value exchanged between the parties. We disposed of net real property owned of $224,208,000, resulting in a loss of $1,687,000 recognized within gain (loss) on real estate dispositions, net within our Consolidated Statements of Comprehensive Income. Consideration transferred to acquire the additional interests in the 29 properties was comprised of the fair value of interests transferred by us of $198,837,000 and $5,776,000 of cash paid for transaction-related expenses. We derecognized $180,497,000 of noncontrolling interests and $22,270,000 of liabilities previously due to Revera with an adjustment of $1,846,000 recognized in capital in excess of par value.
We closed the portion of the transactions predominantly related to the U.S. portfolio during the third quarter of 2023 through (i) the acquisition of the remaining interests in ten properties currently under development or recently developed by Sunrise Senior Living that were previously held within an equity method joint venture owned 34% by us and 66% by Revera, (ii) the disposition of our minority interests in 12 U.S. properties and one Canadian development project and (iii) the disposition of our 34% interest in the Sunrise Senior Living management company. We recorded net real estate investments of $479,525,000 related to the ten acquired and now consolidated properties, which was comprised of $31,456,000 of cash consideration and $448,069,000 of non-cash consideration. Non-cash consideration primarily includes $270,486,000 of assumed mortgage debt secured by the acquired properties, which was subsequently repaid in full by us immediately following the transaction, $47,734,000 of carryover investment from our prior 34% equity method ownership interest and $119,258,000 of fair value interests in the 13 properties transferred by us to Revera. We also derecognized $56,905,000 of equity method investments related to the 13 properties retained by Revera and recorded a gain on real estate dispositions of $62,075,000. In conjunction with this transaction, operations for two of the now wholly-owned properties, along with operations for 26 existing wholly-owned properties, transitioned to Oakmont Management Group.
In April 2024, we closed the Canadian portfolio portion of the transaction through the acquisition of the remaining ownership interest in 71 properties previously held in consolidated joint venture structures in which we owned 75% of the interests, in exchange for the disposition to Revera of our interests in 14 properties. In addition, we received cash of $60,614,000 relating to the net settlement of loans previously made to Revera to fund its share of the pay-off of third party secured debt of the joint ventures. Operations for the 71 retained properties previously transitioned to Cogir Senior Living (53), Levante Living (12) and Optima Living (6) during 2023.
Total net proceeds related to the 14 properties disposed were $430,898,000, which included non-cash consideration from Revera of $434,326,000, comprised primarily of the net fair value of interests received by us of $219,940,000, debt which we were relieved of in the amount of $164,640,000 and an allocation of Revera's noncontrolling interests in the disposed properties of $53,174,000. We disposed of net real property owned of $293,257,000 and paid $3,428,000 of cash transaction-related expenses for the sale of the 14 properties, resulting in a gain of $137,641,000 recognized within gain (loss) on real estate dispositions, net within our Consolidated Statements of Comprehensive Income. Consideration transferred to acquire the additional interests in the 71 properties was primarily comprised of the fair value of interests transferred by us of $219,940,000, a cash payment of $51,986,000 to equalize the value exchanged between the parties and $17,258,000 of cash paid for transaction-related expenses. We derecognized $246,564,000 of Revera's noncontrolling interests in the acquired properties with an adjustment of $42,619,000 recognized in capital in excess of par value.
The non-cash investing activity with respect to the sale of the properties to Revera and non-cash financing activity with respect to the acquisition of Revera's interests have been excluded from our Consolidated Statement of Cash Flows.
Genesis HealthCare
As part of the substantial exit of the Genesis HealthCare ("Genesis") operating relationship, which we disclosed on March 2, 2021, we transitioned the sublease of a portfolio of seven facilities from Genesis to Complete Care Management in the second quarter of 2021. As part of the March 2021 transaction, we entered into a forward sale agreement for the seven properties valued at $182,618,000, which was expected to close when the Welltower-held purchase option became exercisable. As of March 31, 2023, the right of use assets related to the properties were $115,359,000 and were reflected as held for sale with the corresponding lease liabilities of $66,530,000 on our Consolidated Balance Sheet.
12

WELLTOWER INC. AND SUBSIDIARIES
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
On May 1, 2023, we executed a series of transactions that included the assignment of the leasehold interest to a newly formed tri-party unconsolidated joint venture together with Aurora Health Network, Peace Capital (an affiliate of Complete Care Management) and us, and culminated with the closing of the purchase option by the joint venture. The transactions resulted in net cash proceeds to us of $104,240,000 (excluded from the dispositions table above) after our retained interest of $11,571,000 in the joint venture and a gain from the loss of control and derecognition of the leasehold interest of $65,485,000, which we recorded in other income within our Consolidated Statements of Comprehensive Income.
6. Leases
We lease land, buildings, office space and certain equipment. Many of our leases include a renewal option to extend the term from one to 25 years or more. Renewal options that we are reasonably certain to exercise are recognized in our right-of-use assets and lease liabilities.
The components of lease expense were as follows for the periods presented (in thousands):
Six Months Ended
 ClassificationJune 30, 2024June 30, 2023
Operating lease cost: (1)
Real estate lease expenseProperty operating expenses$11,830 $11,093 
Non-real estate investment lease expenseGeneral and administrative expenses3,084 3,586 
Finance lease cost:
Amortization of leased assetsProperty operating expenses2,165 3,628 
Interest on lease liabilitiesInterest expense1,747 1,980 
Sublease incomeRental income (3,933)
Total $18,826 $16,354 
(1) Includes short-term leases which are immaterial.
Supplemental balance sheet information related to leases in which we are the lessee is as follows (in thousands):
 ClassificationJune 30, 2024December 31, 2023
Right of use assets:
Operating leases - real estateRight of use assets, net$281,313 $283,293 
Finance leases - real estateRight of use assets, net78,969 67,676 
Real estate right of use assets, net360,282 350,969 
Operating leases - non-real estate investmentsReceivables and other assets9,660 11,338 
Total right of use assets, net$369,942 $362,307 
Lease liabilities:
Operating leases$302,309 $303,553 
Finance leases91,361 79,677 
Total$393,670 $383,230 
Substantially all of our operating leases in which we are the lessor contain escalating rent structures. Leases with fixed annual rental escalators are generally recognized on a straight-line basis over the initial lease period, subject to a collectability assessment. Rental income related to leases with contingent rental escalators is generally recorded based on the contractual cash rental payments due for the period. During the six months ended June 30, 2024, we wrote off previously recognized straight-line rent receivable and unamortized lease incentive balances of $97,665,000 through a reduction of rental income, which relate to leases for which the collection of substantially all contractual lease payments was no longer probable due primarily to agreements reached to convert Triple-net leased properties to Seniors Housing Operating RIDEA structures (see Note 19).
Leases in our Triple-net and Outpatient Medical portfolios recognized under ASC 842, "Leases" (ASC 842), typically include some form of operating expense reimbursement by the tenant. For the six months ended June 30, 2024, we recognized $753,463,000 of rental income related to operating leases, of which $109,607,000 was for variable lease payments that primarily represents the reimbursement of operating costs such as common area maintenance expenses, utilities, insurance and real estate taxes. For the six months ended June 30, 2023, we recognized $767,498,000 of rental income related to operating leases, of which $108,566,000 was for variable lease payments.
13

WELLTOWER INC. AND SUBSIDIARIES
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
For the majority of our Seniors Housing Operating segment, revenue from resident fees and services is predominantly service-based, and as such, resident agreements are accounted for under ASC 606, "Revenue from Contracts with Customers." Within that reportable segment, we also recognize revenue from residential seniors apartment leases in accordance with ASC 842. The amount of revenue related to these leases was $265,959,000 and $222,452,000 for the six months ended June 30, 2024 and 2023, respectively.
7. Loans Receivable
Loans receivable are recorded on our Consolidated Balance Sheets in real estate loans receivable, net of allowance for credit losses, or for non-real estate loans receivable, in receivables and other assets. Real estate loans receivable consists of mortgage loans and other real estate loans, which are primarily collateralized by a first, second or third mortgage lien, a leasehold mortgage on, or an assignment of the partnership interest in, the related properties, as well as corporate guarantees and/or personal guarantees. Non-real estate loans are generally corporate loans with no real estate backing. Interest income on loans is recognized as earned based upon the principal amount outstanding subject to an evaluation of the risk of credit loss. Accrued interest receivable was $35,569,000 and $31,798,000 as of June 30, 2024 and December 31, 2023, respectively, and is included in receivables and other assets on the Consolidated Balance Sheets. The following is a summary of our loans receivable (in thousands):
 June 30, 2024December 31, 2023
Mortgage loans$1,511,008 $1,057,516 
Other real estate loans306,399 324,660 
Allowance for credit losses on real estate loans receivable(26,205)(20,589)
Real estate loans receivable, net of credit allowance1,791,202 1,361,587 
Non-real estate loans519,513 503,993 
Allowance for credit losses on non-real estate loans receivable(171,888)(173,874)
Non-real estate loans receivable, net of credit allowance347,625 330,119 
Total loans receivable, net of credit allowance$2,138,827 $1,691,706 
The following is a summary of our loan activity for the periods presented (in thousands):    
 Six Months Ended
 June 30, 2024June 30, 2023
Advances on loans receivable$580,145 $76,397 
Less: Receipts on loans receivable138,059 46,493 
Net cash advances (receipts) on loans receivable$442,086 $29,904 
During the six months ended June 30, 2024, we provided a first mortgage loan collateralized by a portfolio of seniors housing communities for $456,199,000. The loan bears interest at 10% per annum.
The allowance for credit losses on loans receivable is maintained at a level believed adequate to absorb potential losses in our loans receivable. The determination of the credit allowance is based on a quarterly evaluation of each of these loans, including general economic conditions and estimated collectability of loan payments. We evaluate the collectability of our loans receivable based on a combination of credit quality indicators, including, but not limited to, payment status, historical loan charge-offs, financial strength of the borrower and guarantors, and nature, extent, and value of the underlying collateral.
A loan is considered to have deteriorated credit quality when, based on current information and events, it is probable that we will be unable to collect all amounts due as scheduled according to the contractual terms of the loan agreement. For those loans we identified as having deteriorated credit quality, we determine the amount of credit loss on an individual basis. Placement on non-accrual status may be required. Consistent with this definition, all loans on non-accrual are deemed to have deteriorated credit quality. To the extent circumstances improve and the risk of collectability is diminished, we will return these loans to income accrual status. While a loan is on non-accrual status, any cash receipts are applied against the outstanding principal balance.

14

WELLTOWER INC. AND SUBSIDIARIES
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
For the remaining loans we assess credit loss on a collective pool basis and use our historical loss experience for similar loans to determine the reserve for credit losses. The following is a summary of our loans by credit loss category (in thousands):
June 30, 2024
Loan categoryYears of OriginationLoan Carrying ValueAllowance for Credit LossNet Loan BalanceNo. of Loans
Deteriorated loans2007 - 2023$196,211 $(169,808)$26,403 6 
Collective loan pool2010 - 2019230,146 (3,021)227,125 16 
Collective loan pool202033,415 (439)32,976 5 
Collective loan pool2021867,202 (11,566)855,636 10 
Collective loan pool2022115,338 (1,514)113,824 16 
Collective loan pool2023343,267 (4,507)338,760 13 
Collective loan pool2024551,341 (7,238)544,103 8 
Total loans$2,336,920 $(198,093)$2,138,827 74 
During the three months ended June 30, 2024, certain secured and unsecured indebtedness payable by Genesis to us, which has a carrying value of $202,434,000, was modified to extend the maturity date to June 30, 2025, with no other changes to the terms.
The total allowance for credit losses balance is deemed sufficient to absorb expected losses relating to our loan portfolio. The following is a summary of the allowance for credit losses on loans receivable for the periods presented (in thousands):                            
Six Months Ended
June 30, 2024June 30, 2023
Balance at beginning of period$194,463 $164,249 
Provision for loan losses, net(1)
6,177 3,233 
Purchased deteriorated loan 19,077 
Loan write-offs(2,399) 
Foreign currency translation(148)(219)
Balance at end of period$198,093